FRANCE - France claims European crown for biotech and pharma
In 2006, French biotech and pharmaceutical companies attracted more venture money than those of any other European country, according to data compiled by unquote".
They raised a total of EUR 169m, against the UK’s EUR 154m, and Denmark’s EUR 100m. France’s three largest deals Cerenis Therapeutics, Novagali Pharma, and Cytheris, contributed more than half of the year’s total. The trend is looking likely to continue, with the closing in January 2007 of Novexel’s huge EUR 50m series-B round. (See France unquote" April 2007.)
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








